Provider Comparison · Pricing Verified April 6, 2026
Mochi vs Ro for GLP-1: Which Provider Is Actually Better in 2026?
Mochi vs Ro comes down to one question most comparison pages won't answer: are you looking for the cheapest compounded GLP-1 path, or the cleanest FDA-approved and insurance-first path? We checked current pricing, medication menus, insurance support, reviews, and cancellation policies against official pages this week. Here's the short version — and then we'll show our work.
By The RX Index Editorial Team · Last verified April 6, 2026 · Affiliate disclosure · Editorial standards · How we verified this
Our Verdict
Ro is the better choice for most people. It's the cleaner FDA-approved and insurance-first path, with the lowest available cash-pay prices for brand-name GLP-1s through direct NovoCare and LillyDirect partnerships. The insurance concierge handles prior authorization on your behalf — included in the $145/month membership. Wegovy pill starts at $149/month cash-pay for lower doses.
Choose Mochi instead if you're paying cash, want lower predictable monthly pricing, and you're comfortable with compounded medication. Mochi's all-in cost: $79/month membership + $99/month compounded semaglutide = $178/month total. Same price regardless of your dose.
Skip both if your own doctor can already prescribe and manage a GLP-1 for you — the extra platform fee from either provider may not add enough value.
Pricing sources: Ro pricing page and joinmochi.com · Verified April 6, 2026 · Independent editorial
Mochi vs Ro at a Glance: Full Comparison
We separated membership cost from medication cost because most comparison pages don't — and that's exactly where the confusion starts.
| Factor | Ro | Mochi |
|---|---|---|
| Best for | Insurance-first, FDA-approved medication | Cash-pay, compounded medication |
| Month 1 membership | $45 | $39 (then $79/mo) |
| Ongoing membership | $145/month | $79/month |
| Compounded semaglutide | No public compounded menu | $99/month + membership ($178 total) |
| Compounded tirzepatide | No public compounded menu | $199/month + membership ($278 total) |
| Cheapest FDA-approved path | Wegovy pill from $149/mo (cash) | Via insurance (price varies) |
| Oral GLP-1 options | Wegovy pill — with clear public pricing | Wegovy pill (now available) |
| Insurance concierge | Yes — free coverage checker, handles prior auth | Helps with prior auth and insurance benefits |
| Lab testing | Included at Quest locations | Recommended but extra cost |
| Support model | Coaching, regular check-ins, unlimited messaging | Video visits with physician + dietitian, in-app messaging |
| Video visits | Available; primarily async messaging | Regular video visits included |
| Cancel policy | Month-to-month, cancel anytime | Month-to-month (prescriptions final once shipped) |
| State availability | All 50 states + DC | All 50 states + DC |
| Trustpilot | ~3.7/5 (3,200+ reviews) | ~4.4/5 (15,600+ reviews) |
| FSA/HSA | Documentation for reimbursement | Supported — confirm payment workflow |
Pricing verified April 6, 2026 from official Ro and Mochi pages. Prices change — always confirm on the provider's site before signing up.
Which One Is Right for YOUR Situation?
The decision in 60 seconds — before you read any further.
Choose Ro if any of these sound like you:
- ✓You have private health insurance. Ro's insurance concierge contacts your insurer directly, submits prior authorization paperwork, and explores alternatives if denied. If your plan covers Wegovy or Zepbound, your monthly medication cost could drop to a copay — sometimes as low as $0–$25 with manufacturer savings programs. That makes the $145/month membership a very different proposition.
- ✓You're paying cash but want FDA-approved medication. Ro has locked in the lowest published cash-pay prices for FDA-approved GLP-1s through direct partnerships with NovoCare and LillyDirect. Wegovy pill starts at $149/month for lower doses. Zepbound KwikPen starts at $299/month for 2.5 mg.
- ✓You hate needles. Ro offers the Wegovy pill (oral semaglutide, approved December 2025 for weight loss) with clear public cash-pay pricing. Mochi now has a Wegovy pill page too, but Ro has clearer pricing upfront.
- ✓You want to minimize regulatory uncertainty. Ro's current public offering is FDA-approved-first. No compounding questions, no wondering if a regulatory change disrupts your treatment plan. For a 12-month GLP-1 journey, that certainty has real value.
Insurance coverage check is free, no commitment required
Choose Mochi if this sounds more like you:
- ✓You're paying cash and want the lowest predictable monthly bill. Mochi's all-in cost for compounded semaglutide is $178/month ($79 membership + $99 medication). That's real, it's predictable, and it doesn't change based on your dose. The same price at 0.5 mg and at 2.5 mg.
- ✓You want regular face-to-face video visits with your provider. Mochi includes regular video visits with a physician or nurse practitioner plus a registered dietitian. If you prefer live interaction over messaging-based care, Mochi delivers it.
Skip both if:
Your own primary care doctor or endocrinologist can prescribe and manage a GLP-1 for you. In that case, the extra monthly membership fee from either platform may not add enough value. If your insurance covers Wegovy or Zepbound through your regular doctor, that's often the cheapest route — you just won't get the coaching, concierge service, or app-based support.
Compare all GLP-1 providers to see every option →
What Most Comparison Pages Get Wrong About Mochi vs Ro
Stale pricing
Mochi's own comparison page (yes, Mochi wrote a page comparing itself to Ro) still lists Ro's first month at $99. Ro's actual pricing page says $45 for month one, $145/month after that. That's not a small discrepancy — it changes the math completely.
Blurring membership cost with medication cost
Almost every comparison page lists one number and calls it 'the price.' But both Mochi and Ro charge a membership fee AND a separate medication fee. If you don't break those apart, you can't actually compare anything.
Treating compounded vs FDA-approved as a footnote
In 2026, it's the whole comparison. The FDA removed semaglutide from its drug shortage list in February 2025, which changed the landscape for compounded GLP-1 medications. That doesn't make compounded access unavailable through all pathways, but it does make it a more nuanced decision than most pages acknowledge.
Real 2026 Pricing: What You'll Actually Pay in Month 1, 3, and 6
The critical thing most pages miss: membership and medication are billed separately on both platforms. The membership gets you access to providers, coaching, and support. The medication is an additional cost on top. If a comparison page shows you one number, they're hiding half the equation.
Ro: Total Monthly Cost by Scenario
| Scenario | Month 1 | Month 2+ | Includes |
|---|---|---|---|
| Wegovy pill, cash-pay (low dose) | ~$194 ($45 + $149) | ~$294 ($145 + $149) | Membership + oral GLP-1 |
| Wegovy pen, insurance covers med | $45 + copay | $145 + copay | Membership + insured Rx |
| Zepbound KwikPen 2.5 mg, cash | ~$344 ($45 + $299) | ~$444 ($145 + $299) | Membership + injectable |
| Zepbound KwikPen 7.5–15 mg, cash | ~$494 ($45 + $449) | ~$594 ($145 + $449) | Membership + injectable |
| Zepbound pen, insurance covers med | $45 + copay | $145 + copay | Membership + insured Rx |
The insurance wildcard
If Ro's concierge team gets your GLP-1 covered, your medication cost could be just a copay. With Novo Nordisk's WeGoTogether savings program, insured patients may pay as little as $0 for Wegovy. That would make your total monthly cost just the $145 membership. Ro's team handles the legwork — and that alone can save you hundreds per month.
Mochi: Total Monthly Cost by Scenario
| Scenario | Month 1 | Month 2+ | Includes |
|---|---|---|---|
| Compounded semaglutide, any dose | ~$138 ($39 + $99) | ~$178 ($79 + $99) | Membership + compounded injectable |
| Compounded tirzepatide, any dose | ~$238 ($39 + $199) | ~$278 ($79 + $199) | Membership + compounded injectable |
| Brand-name via insurance | $39 + copay | $79 + copay | Membership + insured Rx |
“Any dose” means the compounded semaglutide price doesn't increase as your dose goes up — a meaningful advantage for people who need higher doses. Prices include shipping.
The headline comparison
Compounded semaglutide: Mochi = ~$178/month. Ro doesn't have a public compounded menu.
Cheapest FDA-approved oral GLP-1: Ro = ~$294/month (Wegovy pill at starting dose + membership). Mochi now offers the Wegovy pill but Ro has clearer public pricing.
Insured patient whose plan covers the medication: Ro = $145/month + copay. Mochi = $79/month + copay. Mochi's membership is cheaper, but Ro's insurance concierge with a free coverage checker may produce a better real outcome.
FDA-Approved vs Compounded: The Decision That Changes Everything
This is the section nobody else writes well, and it's the one that matters most in 2026. When you compare Mochi and Ro, you're not just comparing two companies — you're choosing between two medication pathways with different costs, regulatory protections, and long-term considerations.
FDA-Approved (Ro's primary focus)
- ✓Went through full clinical trial and regulatory approval process
- ✓Manufacturing follows strict FDA oversight for quality and consistency
- ✓Wegovy, Zepbound, Saxenda, Ozempic — standardized branded medications
- ✓Can be paired with insurance coverage
- ✓No regulatory uncertainty about your refill supply
Compounded (Mochi's pricing advantage)
- •Prepared by specialized licensed pharmacies
- •Prescribed by licensed providers — but NOT FDA-approved as finished products
- •FDA raised concerns about quality variability and misleading marketing
- •Lower cost than brand-name at most doses
- •Regulatory picture shifted after 2025 shortage list removal
What changed in 2025–2026
The FDA removed semaglutide from its drug shortage list in February 2025 and tirzepatide in late 2024. When a drug is on the shortage list, compounding pharmacies have broader authority to produce it. When it comes off, the rules tighten.
Since then, multiple court challenges have kept the situation in flux. Compounded GLP-1s are still available through certain pathways — particularly 503A pharmacies filling patient-specific prescriptions — but the regulatory environment is tighter than during the shortage period. Mochi partners with 503A-licensed pharmacies for its compounded options.
Practical implication: If you're planning a 12–24 month GLP-1 journey (which is typical), it's worth considering whether you want your treatment plan to depend on an evolving regulatory situation. Ro sidestepped this question by focusing on FDA-approved options — higher sticker prices, but minimal risk that a regulatory change disrupts your treatment. For insured patients, that tradeoff often makes sense.
Medication Menu: What Can You Actually Get?
Both platforms connect eligible patients to GLP-1 treatment, but the medication mix is different. Here's what's available — separated clearly by FDA status.
RRo's Medication Menu (April 2026)
FDA-Approved Injectables
- •Wegovy (semaglutide) — weight management
- •Zepbound (tirzepatide pen and vial) — weight management
- •Saxenda (liraglutide)
- •Ozempic (semaglutide; approved for T2D, may be Rx off-label for weight loss)
FDA-Approved Oral
Wegovy pill (oral semaglutide, approved December 2025 for weight loss) — from $149/month cash-pay
MMochi's Medication Menu (April 2026)
Compounded (Not FDA-Approved)
- •Compounded semaglutide — $99/month, same price at all doses
- •Compounded tirzepatide — $199/month, same price at all doses
Brand-Name (Via Insurance)
- •Wegovy, Zepbound/Mounjaro, Ozempic, Saxenda/Victoza
Oral Options
- •Wegovy pill (now available on Mochi platform)
- •Rybelsus (oral semaglutide for type 2 diabetes)
Non-GLP-1 Options
Topiramate, bupropion, naltrexone, orlistat, metformin — for patients not on GLP-1s or as adjunct treatment
Best provider by medication preference
Insurance, Prior Authorization, and Where Ro Pulls Ahead
If you have private health insurance, this section might save you hundreds of dollars a month. It's also where the comparison tilts most clearly in Ro's favor.
Ro's Insurance Concierge
- ✓Contacts your insurer directly to determine coverage
- ✓Submits all prior authorization paperwork
- ✓Explores alternatives and appeal pathways if denied
- ✓Process typically takes 2–3 weeks — you don't make calls
- ✓Free GLP-1 Insurance Coverage Checker before you sign up
- ✓Included in the $145/month membership — no extra fee
- ✓Federal Employee Health Benefits (FEHB) patients specifically eligible
Mochi's Insurance Approach
- •Accepts insurance for brand-name GLP-1 medications
- •Helps with prior authorization submissions
- •Providers can prescribe to pharmacies where manufacturer savings apply
- •No dedicated free coverage checker tool
- •Primary positioning is lower-cost compounded options and clinical support
Government insurance (Medicare, Medicaid, Tricare)
This is a pain point for both platforms. Ro currently does not coordinate GLP-1 coverage for most government insurance plans, though FEHB patients are specifically eligible. If you're on Medicare or Medicaid, your best path may be working with your own doctor — recent policy changes have expanded some GLP-1 coverage for certain government plan holders.
The bottom line on insurance
If you have private insurance that might cover a GLP-1: start with Ro. Their concierge does the heavy lifting, and if you're approved, the savings on medication cost alone will dwarf the difference in membership fees between the two platforms.
If you already know insurance won't cover it: the concierge doesn't change the picture for you, and the comparison shifts to Ro's cash-pay prices vs Mochi's compounded prices.
Find out what your plan covers before you commit
Support, Visits, and What the Day-to-Day Experience Feels Like
Medication is only part of the equation. How often you see a provider, how easily you can reach someone when side effects hit, whether anyone is actually coaching you — this matters more than most people expect when they sign up.
Mochi's Model: High-Touch, Video-First
- •Regular video visits with prescribing physician or NP
- •Access to a registered dietitian
- •In-app messaging with your care team
- •Provider who knows your name and your case
- •Live face-time for dose titration and side effect management
Ro's Model: Streamlined, Admin-First
- •Primarily async messaging — communicate through the platform
- •Regular check-ins with option to schedule live appointments
- •Unlimited provider messaging
- •Free lab testing at Quest Diagnostics (at provider discretion)
- •Evidence-based weight loss curriculum included
- •Insurance concierge included in membership
Which model is right for you?
Both approaches work. The medication is the primary driver of weight loss results, not the care model. But the right support structure keeps you on the medication longer — and consistency is what produces results. If you value face-to-face interaction: Mochi. If you value efficiency, insurance navigation, and a streamlined platform: Ro.
Reviews, Complaints, and What Real Patients Say
What patients praise:
- →Easy, transparent onboarding — signed up, consulted, received medication within days
- →Responsive providers. Video-visit model appears repeatedly in positive reviews
- →“My doctor listened to me and we were able to make decisions right away.”
What patients praise:
- →Insurance and administrative support: “Prior authorization was handled in less than a week.”
- →Longer-term members report meaningful results with medication + coaching combo
- →“Worth what I am paying” — describing the insurance help
Reading the reviews correctly
Mochi's higher Trustpilot score reflects its larger, more video-visit-engaged customer base. Ro's lower score partly reflects users who enrolled for insurance help and felt the membership cost was high when coverage didn't come through. Both platforms have customers getting real results. Review themes on both platforms are mostly about cost, customer service, shipping, and communication — not about medication quality or clinical outcomes.
What Weight Loss Results Should You Expect?
Semaglutide (Wegovy)
~15% average body weight loss over 68 weeks in clinical trials, combined with diet and exercise. For someone starting at 250 lbs, that's roughly 37 lbs. Ro reports its 12-month Body program members average 15% body weight loss with branded GLP-1 medication, diet, and exercise combined.
Tirzepatide (Zepbound)
~20% average body weight loss in clinical trials — the strongest results of any GLP-1 medication currently available.
Oral semaglutide (Wegovy pill)
Same active ingredient as injectable Wegovy. The convenience of a daily pill instead of a weekly injection is meaningful for long-term adherence — and adherence is what drives results.
The real variable: how long you stay on treatment
The people who get the best results stay on treatment for 6–12 months minimum and pair the medication with even modest improvements in eating and activity. The provider that fits your budget well enough that you can sustain treatment for that long is the one that'll produce the best outcome for you. If Mochi's lower monthly cost keeps you in the game longer, that matters. If Ro's insurance concierge gets your medication covered, that matters equally. Pick the path you can stick with.
The Honest Tradeoff: What Each Provider Does NOT Do Well
Ro does NOT offer the lowest flat monthly GLP-1 cost
If your only priority is paying as little as possible each month for semaglutide — and you're comfortable with compounded medication — Ro won't beat Mochi's $178/month all-in price. That's a fact.
But here's why that may not matter: because Ro focuses on FDA-approved medications and insurance navigation, many Ro members end up paying less than they would on Mochi's compounded plan — once their insurance kicks in. The sticker price is higher. The out-of-pocket reality, for insured patients, is often lower. And you get medication that went through the full FDA approval process.
Mochi does NOT have Ro's insurance depth or FDA-first medication access
If you have insurance that might cover brand-name GLP-1s, Mochi's concierge is less visible and less dedicated than Ro's. And if your priority is specifically FDA-approved medication with the clearest possible regulatory path, Mochi's primary value proposition is in its compounded options — which is a different bet.
If you know for certain you're paying cash with no insurance option, and compounded semaglutide is what you want, Mochi is the better fit. You might also want to check out MEDVi, which offers competitive compounded pricing with both compounded and FDA-approved options.
Can You Cancel? Can You Switch? What Happens to Your Medication?
Cancelling Ro
- •Month-to-month, no long-term contract
- •Cancel through online account or by emailing support
- •No cancellation fee, no minimum commitment
- •If not eligible after initial review, not charged the $145/month
- •Membership and medication billed separately — cancelling membership doesn't auto-cancel existing prescription
Cancelling Mochi
- •Month-to-month standard plan (longer prepaid at reduced rates)
- •No lock-in on the monthly option
- •Prescription medication sales are final once shipped
- •Time cancellation before next shipment cycle
- •Confirm current cancellation path in account settings before enrolling
Switching from one to the other
- →Get documentation of your current prescription, dose, and most recent lab work before you cancel
- →Start the new provider's intake process before your current supply runs out — onboarding typically takes several days
- →Inform your new provider of your current dose so they can continue your titration schedule without restarting at the lowest dose
- →If switching with active insurance prior authorizations: authorizations are typically tied to the prescribing provider, not the patient — your new provider may need to resubmit
How We Verified This Comparison
Mochi vs Ro FAQ
Is Mochi cheaper than Ro?+
Is Ro better if my insurance might cover Wegovy or Zepbound?+
Does Mochi only offer compounded medication?+
Does Ro offer compounded GLP-1s?+
Which is better for semaglutide?+
Which is better for tirzepatide?+
Which is better if I want a pill instead of an injection?+
Are Mochi and Ro available in all 50 states?+
How hard is it to cancel Ro or Mochi?+
Can I switch from Ro to Mochi without restarting treatment?+
Can I use HSA or FSA funds for Mochi or Ro?+
When should I skip both Mochi and Ro and use my own doctor?+
You've Done the Research. Now Decide.
You're reading this page because you've narrowed it down to two solid options. The comparison paralysis ends here.
Start with Ro if you have insurance or want FDA-approved medication
Their free insurance coverage checker costs nothing and tells you where you stand before you commit a dollar. If your plan covers Wegovy or Zepbound, you could save hundreds per month — and you'll know within minutes.
Check Your GLP-1 Insurance Coverage on Ro →Free, no commitment required
Start with Mochi if you're paying cash and want the lowest predictable monthly cost
Compounded semaglutide at $178/month all-in, same price at every dose. Regular video visits with your provider. A warm, supportive care model.
See Mochi's Current Pricing →Related comparisons and guides
- Best GLP-1 Telehealth Providers Overall — see all your options side by side
- Mochi vs Hims for GLP-1: 9 Real Differences in 2026 (Actual Prices)
- MEDVi vs Mochi Health: Prices, Support & Best Fit
- Ro vs Henry Meds: 9 Real Differences in 2026
- Ro vs Noom: 9 Real Differences in 2026
- Best GLP-1 Providers That Accept Insurance (2026)
- Does Insurance Cover Wegovy for Weight Loss? (2026)
- Cheapest Wegovy Without Insurance in 2026
Last updated: April 6, 2026. Published by The RX Index Editorial Team.
The RX Index is an independent health information resource. We may earn commissions through affiliate partnerships with Ro, but editorial content is never influenced by compensation. Affiliate disclosure · Editorial standards